Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Luting Qiu"'
1
Akademický článek
Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advanced NSCLC
Autor: Yongchang Zhang, Liang Zeng, Xiangyu Zhang, Yizhi Li, Lingli Liu, Qinqin Xu, Haiyan Yang, Wenjuan Jiang, Analyn Lizaso, Luting Qiu, Ting Hou, Jun Liu, Ling Peng, Nong Yang
Publikováno v: BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background The combination of bevacizumab and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) could prolong progression-free survival (PFS) in patients with EGFR-mutant advanced non-small-cell lung cancer (NSCLC). Our
Externí odkaz: https://doaj.org/article/91ea5f3f48054fc69935c7709ed104d7
Zobrazit plný text záznamu
2
Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advanced NSCLC
Autor: Xiangyu Zhang, Jun Liu, Analyn Lizaso, Haiyan Yang, Lingli Liu, Yizhi Li, Ling Peng, Luting Qiu, Ting Hou, Yongchang Zhang, Liang Zeng, Qinqin Xu, Wenjuan Jiang, Nong Yang
Publikováno v: BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
BMC Medicine
Background The combination of bevacizumab and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) could prolong progression-free survival (PFS) in patients with EGFR-mutant advanced non-small-cell lung cancer (NSCLC). Our study in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a97342c6962b5d0cc105efcb6fbaf86
https://doaj.org/article/91ea5f3f48054fc69935c7709ed104d7
Zobrazit plný text záznamu
4
Abstract 5232: Next-generation sequencing revealed clonal architecture and faciliated diagnosis of patients with multiple lung tumors: An analysis of 12 cases
Autor: Wenyang Jiang, Wei Wang, Luting Qiu, Xiao Zou, Zhiqiu Chen, Qing Geng
Publikováno v: Cancer Research. 82:5232-5232
Diagnosing multiple lung tumors as multiple primary lung cancer (MPLC) or intrapulmonary metastasis (IPM) has important therapeutic implications. The clinical applicability of next-generation sequencing (NGS) has been explored, although there is curr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce963d60fea050a6bebac045299e8472
https://doi.org/10.1158/1538-7445.am2022-5232
Zobrazit plný text záznamu
5
Assessment of noise annoyance level of shield tunneling machine drivers under noisy environments based on combined physiological activities
Autor: Luting Qiu, Xuejiao Xing, Lang Li, Qunzhou Yu, Jun Hou, Heng Li, Botao Zhong, Hanbin Luo
Publikováno v: Applied Acoustics. 179:108045
Noise annoyance is widely recognized as an expression of psychological strain in acoustic environments. It is closely related to the cognitive capability, risk perception, and decision-making ability of workers and can lead to unsafe behavior and uns
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75f7ea26d56bca1681157fec655a3cb1
https://doi.org/10.1016/j.apacoust.2021.108045
Zobrazit plný text záznamu
6
Sputum supernatant as a viable alternative for liquid biopsy in advanced non-small cell lung cancer
Autor: Xinqing Lin, Ming Liu, Luting Qiu, Bingpeng Guo, Zhange Chen, Jianhui Wu, Xiaohong Xie, Chengzhi Zhou, Xiao Zou, Yinyin Qin
Publikováno v: Journal of Clinical Oncology. 39:3053-3053
3053 Background: Sputum has previously attracted attention as a potential medium for detecting genetic and epigenetic alterations in early-stage lung cancer. Recent progress in advanced non-small cell lung cancer (aNSCLC) has highlighted plasma as an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::58f9ca74a0ed9313c7150d5ddbba9dd2
https://doi.org/10.1200/jco.2021.39.15_suppl.3053
Zobrazit plný text záznamu
7
Akademický článek
Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advanced NSCLC.
Autor: Zhang, Yongchang1,2,3 (AUTHOR) zhangyongchang@csu.edu.cn, Zeng, Liang1 (AUTHOR), Zhang, Xiangyu1 (AUTHOR), Li, Yizhi1 (AUTHOR), Liu, Lingli1,2 (AUTHOR), Xu, Qinqin4 (AUTHOR), Yang, Haiyan1 (AUTHOR), Jiang, Wenjuan1 (AUTHOR), Lizaso, Analyn5 (AUTHOR), Qiu, Luting5 (AUTHOR), Hou, Ting5 (AUTHOR), Liu, Jun6 (AUTHOR), Peng, Ling7 (AUTHOR), Yang, Nong1,2 (AUTHOR) yangnong0217@163.com
Publikováno v: BMC Medicine. 10/18/2021, Vol. 19 Issue 1, p1-11. 11p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje